{
  "id": 7682519,
  "title": "Lawsuit over retraction of abortion pill papers heads toward arbitration decision",
  "url": "https://urgent.news/2026/09/15/lawsuit-over-retraction-of-abortion-pill-papers-heads-toward",
  "topic": "world",
  "section": "World",
  "published": "2026-09-15T19:17:12.000Z",
  "source": {
    "name": "Retraction Watch",
    "slug": "retraction-watch",
    "url": "https://retractionwatch.com/2026/09/15/lawsuit-over-retraction-of-abortion-pill-papers-heads-toward-arbitration-decision/"
  },
  "original_language": "en",
  "account": "A legal dispute over the retraction of three articles on the abortion pill, mifepristone, is set to be decided through arbitration this month. Ten researchers filed a lawsuit against publisher Sage in 2024, alleging inconsistent retraction standards based on the researchers' perceived \"pro-life affiliations.\" The dispute stems from a retraction notice citing undeclared conflicts of interest by the authors, despite their declarations of no conflicts. Further investigation revealed issues with the study design, methodology, and findings of two articles, and unsupported assumptions in the third. The retracted articles, published between 2019 and 2022, discussed emergency room visits, physician characteristics, and complications from chemical abortions, which now constitute nearly two-thirds of all abortions in the U.S. One of the retracted papers was cited by a federal judge in 2023 when he temporarily suspended mifepristone, but the U.S. Supreme Court later rejected the suspension. A Louisiana challenge to the FDA's rule allowing telehealth and mail delivery of mifepristone has also been ongoing. The arbitration process, required by the researchers' publishing agreements, is scheduled for a status conference on September 21.",
  "summary": "A legal challenge by authors over three retracted articles about mifepristone is set for an arbitration conference this month as nationwide debate over the abortion pill heats up at the appellate level. Ten researchers sued Sage in 2024 after the publisher retracted three of their papers about the purported dangers of mifepristone, a medication that … Continue reading Lawsuit over retraction of…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}